Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kleinschmidt

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Diabetes, Obesity & Metabolism|June 20, 2008
Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunctionC L Oltman, E P Davidson, L J Coppey, et al.
Diabetes|January 30, 2007
Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural diseaseEric P Davidson, Travis L Kleinschmidt, Christine L Oltman, et al.
Experimental Diabetes Research|June 19, 2009
Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688Eric P Davidson, Lawrence J Coppey, Travis L Kleinschmidt, et al.
European Journal of Pharmacology|November 3, 2010
Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic ratsChristine L Oltman, Eric P Davidson, Lawrence J Coppey, et al.
Obesity (Silver Spring, Md.)|January 29, 2008
Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatinChristine L Oltman, Eric P Davidson, Lawrence J Coppey, et al.
Vascular Pharmacology|January 1, 2008
Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetesChristine L Oltman, Travis L Kleinschmidt, Eric P Davidson, et al.
Diabetes, Obesity & Metabolism|November 1, 2007
Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverseC L Oltman, E P Davidson, L J Coppey, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Diabetes, Obesity & Metabolism|June 20, 2008
Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunctionC L Oltman, E P Davidson, L J Coppey, et al.
Diabetes|January 30, 2007
Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural diseaseEric P Davidson, Travis L Kleinschmidt, Christine L Oltman, et al.
Experimental Diabetes Research|June 19, 2009
Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688Eric P Davidson, Lawrence J Coppey, Travis L Kleinschmidt, et al.
European Journal of Pharmacology|November 3, 2010
Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic ratsChristine L Oltman, Eric P Davidson, Lawrence J Coppey, et al.
Obesity (Silver Spring, Md.)|January 29, 2008
Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatinChristine L Oltman, Eric P Davidson, Lawrence J Coppey, et al.
Vascular Pharmacology|January 1, 2008
Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetesChristine L Oltman, Travis L Kleinschmidt, Eric P Davidson, et al.
Diabetes, Obesity & Metabolism|November 1, 2007
Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverseC L Oltman, E P Davidson, L J Coppey, et al.
Pageof 2